TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2178488

Group type: EXPERIMENTAL
Intervention: 20 mg lidocaine i.v.
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Lidocaine combined with venous congestives
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Dilution of etomidate with water (1:1 ratio)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Combined lidocaine with venous congestives
Number of subjects: 161

Group type: COMPARATOR
Intervention: Remaining groups (without lidocaine)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Contralateral venous cannula without etomidate
Number of subjects: 161
Study: 7203722

Group type: EXPERIMENTAL
Intervention: d,l‐oxyfedrine (Myofedrin)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: l‐oxyfedrine (ildamen)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 31443627

Group type: EXPERIMENTAL
Intervention: Pilates-based exercise treatment (n = 148)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Educational booklet (n = 74)
Number of subjects: 222
Study: 30141776

Group type: EXPERIMENTAL
Intervention: 3 monthly sessions with booster 3 months later (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2 sessions every 3 months (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 27529709

Group type: EXPERIMENTAL
Intervention: Pneumatic broadband light (PBBL) plus adapalene gel 0.3%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adapalene gel 0.3% monotherapy
Number of subjects: 0
Study: 24619106

Group type: EXPERIMENTAL
Intervention: Calcium citrate (600 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dairy products (600 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Calcium citrate and Dairy products
Number of subjects: 11
Study: 22110084

Group type: EXPERIMENTAL
Intervention: Increasing stimulation frequency
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Increasing stimulation amplitude
Number of subjects: 1
Study: 20573799

Group type: EXPERIMENTAL
Intervention: Caffeine intake (quintiles: 22, 135, 285, 402, and 656 mg/d)
Number of subjects: 33638
Study: 18638410

Group type: EXPERIMENTAL
Intervention: Osteopathy treatment (n = 15 infants)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n = 13 infants)
Number of subjects: 34
Study: 16022950

Group type: EXPERIMENTAL
Intervention: X-Sizer thrombectomy
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 201
Study: 12500862

Group type: EXPERIMENTAL
Intervention: Judgments of nonhuman targets, objects, and concepts
Number of subjects: 6
Study: 10513500

Group type: EXPERIMENTAL
Intervention: 6-week exercise and educational program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 41
Study: 7730703

Group type: EXPERIMENTAL
Intervention: 18 monthly doses of WHO/MDT
Number of subjects: 305

Group type: COMPARATOR
Intervention: 30 monthly doses of WHO/MDT
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 305
Study: 2210598

Group type: EXPERIMENTAL
Intervention: 10 mg nifedipine orally one hour prior to anesthetic induction
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Nifedipine infusion of 0.30 micron/kg/min prior to extracorporeal circulation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no nifedipine infusion)
Number of subjects: 56
Study: 7378259

Group type: EXPERIMENTAL
Intervention: Debrisoquine (30 mg oral dose)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Amitriptyline (75 mg p.o.) given 2 h before debrisoquine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chronic debrisoquine therapy
Number of subjects: 14
Study: 31111502

Group type: EXPERIMENTAL
Intervention: Proton therapy (PRT) with a median dose of 73.8 Gy (RBE; range 68.4-79.2 Gy); 17 patients received adjuvant PRT, 3 received definitive PRT; PRT-only (n=6) or combination PRT/intensity-modulated radiotherapy (IMRT) (n=14)
Number of subjects: 20
Study: 28641030

Group type: EXPERIMENTAL
Intervention: 15 mg E4 combined with 3 mg DRSP
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: 20 mg E4 combined with 3 mg DRSP
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: 15 mg E4 combined with 150 μg LNG
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: 20 mg E4 combined with 150 μg LNG
Number of subjects: 396

Group type: COMPARATOR
Intervention: E2V combined with DNG
Number of subjects: 396
Study: 23904178

Group type: EXPERIMENTAL
Intervention: Drawing and telling about their presenting problem
Number of subjects: 33

Group type: COMPARATOR
Intervention: Telling only
Number of subjects: 33
Study: 23748252

Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg twice per day) and celecoxib (100 mg twice per day) for 14 days before THA and for three weeks after discharge.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for the same duration as the intervention group.
Number of subjects: 0
Study: 21426884

Group type: EXPERIMENTAL
Intervention: 1,600 mg of MESNA plus 0.9% saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo plus 0.9% saline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MESNA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 20052918

Group type: EXPERIMENTAL
Intervention: Cycloferon addition to main therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Main therapy without cycloferon
Number of subjects: 0
Study: 18411913

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy (HRT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Hormonal supplement therapy per oss (HST)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Transdermal placebo (Control)
Number of subjects: 65
Study: 15132876

Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine-hydrochloride: 10 mg two times a day for one month
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Flavoxate HCI-neptumus: 200 mg three times a day for one month
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 10678582

Group type: EXPERIMENTAL
Intervention: PathVysion HER‐2 fluorescence in situ hybridization (FISH) assay
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Analysis of 20 nuclei
Number of subjects: 4
Study: 9071894

Group type: EXPERIMENTAL
Intervention: Quality of Life assessment in clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods for improving compliance in QoL assessments
Number of subjects: 0
Study: 8444626

Group type: EXPERIMENTAL
Intervention: Walking education program
Number of subjects: 0
Study: 2417579

Group type: EXPERIMENTAL
Intervention: Peripheral scatter argon laser photocoagulation
Number of subjects: 401
Study: 31322116

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g intravenous bolus followed by an 8‐hour 1‐g infusion)
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 2325

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 2325
Study: 29843449

Group type: EXPERIMENTAL
Intervention: Warning labels (WLs)
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Traffic-Light labels (TLLs)
Number of subjects: 1607
Study: 27928115

Group type: EXPERIMENTAL
Intervention: PSG (pre‐germinated brown rice bran extract)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (corn oil)
Number of subjects: 60
Study: 22530793

Group type: EXPERIMENTAL
Intervention: Fresh-frozen bone blocks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Autologous bone blocks
Number of subjects: 24
Study: 22526405

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Brief supportive psychotherapy (BSP)
Number of subjects: 31
Study: 20197354

Group type: EXPERIMENTAL
Intervention: Telemedicine treatment for 4 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional treatment for 4 months
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Telemedicine treatment after conventional therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional treatment after telemedicine therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall service delivery
Number of subjects: 34
Study: 19347813

Group type: EXPERIMENTAL
Intervention: CD36 expression on monocytes in obese women (mean 62.99 ± 18.07)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CD36 expression on monocytes in nonobese women (mean 82.5 ± 22.93)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Body mass, BMI, WHR, waist and hip circumferences in obese women
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glucose and insulin concentrations in 0', 30', 60' of OGTT in obese women
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HOMA and FIRI values in obese women
Number of subjects: 30
Study: 15996385

Group type: EXPERIMENTAL
Intervention: New surgical technique using acellular dermal matrix graft (ADMG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional technique using acellular dermal matrix graft (ADMG)
Number of subjects: 32
Study: 12050268

Group type: EXPERIMENTAL
Intervention: rhIGF‐I (30 microg/kg sc twice daily) and oral contraceptive (Ovcon 35, 35 microg ethinyl estradiol and 0.4 mg norethindrone)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rhIGF‐I alone (30 microg/kg sc twice daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral contraceptive alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: No active therapy
Number of subjects: 60
Study: 10968690

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 40 microg GM-CSF
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 80 microg GM-CSF
Number of subjects: 30
Study: 8623971

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine (NG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine and IV N‐butyl‐scopolamine (NSG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 27
Study: 1375685

Group type: EXPERIMENTAL
Intervention: Anistreplase (doses ranging from 3.75 to 35 IU, 60% received 30 IU)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Delay from onset of symptoms to treatment
Number of subjects: 424
Study: 3970454

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 14
Study: 31155559

Group type: EXPERIMENTAL
Intervention: FDC‐ODT
Number of subjects: 13

Group type: COMPARATOR
Intervention: IC‐ODTs
Number of subjects: 13
Study: 29111863

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise intervention (jumping rope, 75 min/session, 3 sessions/week for 12 weeks)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Reading control group
Number of subjects: 75
Study: 25985403

Group type: EXPERIMENTAL
Intervention: Daily oral tenofovir (PrEP)
Number of subjects: 2413
Study: 23238930

Group type: EXPERIMENTAL
Intervention: Endurance training (TR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 50
Study: 21343755

Group type: COMPARATOR
Intervention: MVI 100
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: MVI 200
Number of subjects: 374
Study: 19594663

Group type: EXPERIMENTAL
Intervention: CTG
Number of subjects: 40

Group type: COMPARATOR
Intervention: CTG+R
Number of subjects: 40
Study: 16562387

Group type: EXPERIMENTAL
Intervention: PCEA (patient controlled epidural analgesia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: PCA (peripheral patient controlled analgesia)
Number of subjects: 0
Study: 12598483

Group type: EXPERIMENTAL
Intervention: Exercise group (12 subjects) - supine cycle ergometry at 75% of pre-bed rest heart rate maximum for 90 min/day during HDT bed rest
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonexercise group (8 subjects)
Number of subjects: 20
Study: 11508561

Group type: EXPERIMENTAL
Intervention: Intensive in-home interventions
Number of subjects: 238

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 238
Study: 9207870

Group type: EXPERIMENTAL
Intervention: Axillary dissection prepared by liposuction (Suzanne's procedure)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Functional lymphadenectomy by classical dissection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Radical mastectomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 200
Study: 7962030

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Porous-coated femoral stem
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated femoral stem
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (Cemented, Hydroxyapatite-coated, Porous-coated)
Number of subjects: 60
Study: 3455212

Group type: EXPERIMENTAL
Intervention: Steroid treatment (ST)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-steroid treatment (NT)
Number of subjects: 38
Study: 2115754

Group type: EXPERIMENTAL
Intervention: Use of triage criteria by private practitioners during intervention months
Number of subjects: 404
Study: 30414289

Group type: EXPERIMENTAL
Intervention: Increased serum galectin-3 in hyperglycemic patients
Number of subjects: 3082
Study: 28491474

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Higher self-efficacy scores for healthy eating
Number of subjects: 62

Group type: COMPARATOR
Intervention: Racial subgroups
Number of subjects: 62
Study: 25495610

Group type: EXPERIMENTAL
Intervention: ICAM-1 at 1 month
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: ICAM-1 at 6 months
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: IL-10 at 6 months
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: ICAM-1 trajectory
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: ICAM-1 and IL-10
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: CRP levels at 1 month
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: ICAM-1 levels at baseline, 1 month and 6 months
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: IL-6 levels at 1 month and 6 months
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: IL-10 levels at 6 months
Number of subjects: 803
Study: 24047926

Group type: EXPERIMENTAL
Intervention: Diabetes self-management education intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 252
Study: 21808863

Group type: EXPERIMENTAL
Intervention: Cobalt-chromium stents
Number of subjects: 187

Group type: COMPARATOR
Intervention: Stainless steel stents
Number of subjects: 187
Study: 17914031

Group type: EXPERIMENTAL
Intervention: rs17880135 in the 3' region of superoxide dismutase 1 (SOD1)
Number of subjects: 1362

Group type: EXPERIMENTAL
Intervention: Additional SOD1 variants (rs202446, rs9974610, rs204732)
Number of subjects: 1362

Group type: EXPERIMENTAL
Intervention: rs17880135 and rs17881180
Number of subjects: 1362
Study: 16814890

Group type: EXPERIMENTAL
Intervention: Fermented millet drink (KSW) 300 ml daily for 5 days
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard treatment for diarrhoea at local clinic
Number of subjects: 184
Study: 16027693

Group type: EXPERIMENTAL
Intervention: Continuous nasogastric feeding
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intermittent nasogastric feeding
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intermittent orogastric feeding
Number of subjects: 70
Study: 11176557

Group type: EXPERIMENTAL
Intervention: $5 cash incentive
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: $10 cash incentive
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: $20 cash incentive
Number of subjects: 873

Group type: COMPARATOR
Intervention: Control (no incentive)
Number of subjects: 873
Study: 9274231

Group type: EXPERIMENTAL
Intervention: Increased parental involvement in post-operative care through information and education.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 7944428

Group type: EXPERIMENTAL
Intervention: Intermittent infusion of ADM or MMC
Number of subjects: 57

Group type: COMPARATOR
Intervention: No regional chemotherapy
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 5-FU
Number of subjects: 57

Group type: COMPARATOR
Intervention: No local chemotherapy
Number of subjects: 57
Study: 3232498

Group type: EXPERIMENTAL
Intervention: Nalbuphine 20 mg I.M.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pentazocine 30 mg I.M.
Number of subjects: 60
Study: 29705231

Group type: EXPERIMENTAL
Intervention: Microvascular Decompression (MVD)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Gamma Knife Surgery (GKS)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Both MVD and GKS
Number of subjects: 441
Study: 29919984

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 73
Study: 25276627

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1g)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (iv)
Number of subjects: 80
Study: 22541055

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)‐rich oil
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)‐rich oil
Number of subjects: 90

Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Increased erythrocyte DHA
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Increased erythrocyte DHA in subgroup of 17 children with learning difficulties
Number of subjects: 90
Study: 20822500

Group type: EXPERIMENTAL
Intervention: 225 mg of polaprezinc in addition to standard therapies
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard therapies only
Number of subjects: 79
Study: 19082232

Group type: EXPERIMENTAL
Intervention: Radiofrequency ultrasonic dissector (US)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Laser
Number of subjects: 528
Study: 16907767

Group type: EXPERIMENTAL
Intervention: Cement-retained crowns
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Screw-retained crowns
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both crown types
Number of subjects: 80

Group type: COMPARATOR
Intervention: Esthetic fulfillment survey
Number of subjects: 80
Study: 12794385

Group type: EXPERIMENTAL
Intervention: Genetic susceptibility testing
Number of subjects: 206
Study: 11252222

Group type: EXPERIMENTAL
Intervention: Audit and feedback, consensus building, reminder system
Number of subjects: 54
Study: 8982878

Group type: EXPERIMENTAL
Intervention: Manual/mechanical compression technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical compression technique
Number of subjects: 0
Study: 7520857

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appetite stimulants (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteral and parenteral alimentation (under evaluation)
Number of subjects: 0
Study: 3608051

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5 percent
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine 1 percent
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: No injection (Control)
Number of subjects: 100
Study: 31829427

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention (in-service training, mentorship, supportive supervision, and infrastructure support)
Number of subjects: 784

Group type: COMPARATOR
Intervention: Control group (12 facilities)
Number of subjects: 784

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention (high implementation)
Number of subjects: 784
Study: 30793700

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural approaches (RAFT) plus usual care (Arthritis Research UK fatigue booklet)
Number of subjects: 333
Study: 28050704

Group type: EXPERIMENTAL
Intervention: Swallowing action immediately before intravenous fentanyl (S group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No swallowing action (non-S group)
Number of subjects: 0
Study: 25855501

Group type: EXPERIMENTAL
Intervention: Femtosecond laser setting at 140 nJ (spot distance 3.0 µm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Femtosecond laser setting at 170 nJ (spot distance 4.5 µm)
Number of subjects: 22
Study: 23774096

Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Conventional thyroidectomy (CT)
Number of subjects: 224
Study: 21500582

Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative treatment (Control)
Number of subjects: 60
Study: 19674724

Group type: EXPERIMENTAL
Intervention: Maximum limit statements (e.g., maximum distances, maximum durations, maximum prices, maximum delivery times)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Mistaken maxima
Number of subjects: 3

Group type: COMPARATOR
Intervention: Information preferences
Number of subjects: 3
Study: 17344008

Group type: EXPERIMENTAL
Intervention: Brachytherapy with Ir-192 (mean dose 30 Gy) and external radiotherapy (mean dose 50 Gy)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Stent insertion only
Number of subjects: 21

Group type: COMPARATOR
Intervention: Stent insertion and brachytherapy only (control group of 8 patients)
Number of subjects: 21
Study: 15547164

Group type: EXPERIMENTAL
Intervention: Computerized physician standing orders
Number of subjects: 3777

Group type: COMPARATOR
Intervention: Computerized physician reminders
Number of subjects: 3777
Study: 11303344

Group type: EXPERIMENTAL
Intervention: Anti-reflux treatment in reflux positive HRAD patients
Number of subjects: 107

Group type: COMPARATOR
Intervention: No treatment for reflux in reflux negative HRAD patients
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: All patients with apnea
Number of subjects: 107
Study: 9851957

Group type: EXPERIMENTAL
Intervention: Systemic exercise training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 7988260

Group type: EXPERIMENTAL
Intervention: CAP (cyclophosphamide, doxorubicin, cisplatin) chemotherapy plus radiation therapy as preoperative or neoadjuvant therapy
Number of subjects: 39
Study: 2691239

Group type: EXPERIMENTAL
Intervention: Nutritional support diet (50 kcal/kg bodyweight/d and 1.5 g protein/kg bodyweight/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard diet prescribed by attending physician
Number of subjects: 36